|
ZNF652 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.164400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.617080E-03 |
| Normal-vs-Stage2 |
1.320590E-03 |
| Normal-vs-Stage3 |
5.722600E-03 |
| Normal-vs-Stage4 |
7.590600000007E-05 |
| Stage1-vs-Stage2 |
1.447620E-01 |
| Stage1-vs-Stage3 |
8.075600E-01 |
| Stage1-vs-Stage4 |
1.143820E-01 |
| Stage2-vs-Stage3 |
2.943200E-01 |
| Stage2-vs-Stage4 |
8.719800E-01 |
| Stage3-vs-Stage4 |
2.355000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.987600E-04 |
| Normal-vs-AfricanAmerican |
4.778100E-04 |
| Normal-vs-Asian |
9.006200E-01 |
| Caucasian-vs-AfricanAmerican |
2.364800E-01 |
| Caucasian-vs-Asian |
2.530400E-01 |
| AfricanAmerican-vs-Asian |
1.082210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.554800E-04 |
| Normal-vs-Female |
1.563900E-03 |
| Male-vs-Female |
1.627170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.393900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.220300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.647330E-04 |
| Normal-vs-Age(81-100Yrs) |
1.439430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.768200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.904400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.045400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.137000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.574200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.926370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.321800E-01 |
| Normal-vs-Grade 2 |
1.532030E-02 |
| Normal-vs-Grade 3 |
4.27840000000179E-05 |
| Normal-vs-Grade 4 |
3.048600E-04 |
| Grade 1-vs-Grade 2 |
6.598200E-01 |
| Grade 1-vs-Grade 3 |
2.054000E-01 |
| Grade 1-vs-Grade 4 |
1.575220E-01 |
| Grade 2-vs-Grade 3 |
3.798300E-02 |
| Grade 2-vs-Grade 4 |
7.508200E-02 |
| Grade 3-vs-Grade 4 |
9.222800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.477760E-03 |
| Normal-vs-ccB subtype |
1.679740E-02 |
| ccA subtype-vs-ccB subtype |
9.355000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.021300E-03 |
| Normal-vs-N1 |
3.588200E-01 |
| N0-vs-N1 |
4.897200E-01 |
|
|
